Realising the promise of genomic testing across oncology
pharmaphorum
AUGUST 4, 2022
Unlocking the secrets of the human genome has long been an ambitious pursuit for researchers around the world.
52 
Can genetic data be a magic bullet for drug R&D?
pharmaphorum
JANUARY 24, 2023
Rather than be provided a therapy that has been tested across a broad range of the population, there are now many therapies on the market that are designed specifically to work for sub-populations within disease areas. The information gathered from the project is still providing insights today, a decade later.
Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Where is the drug discovery expertise happening in the UK?
Drug Discovery World
OCTOBER 16, 2023
Dr Salako says there are some clear fields of work associated with different areas, which include: Hertfordshire as a cell and gene therapy hub, with a number of companies in this space clustered around Stevenage. billion in funding. “The Cambridge is a focal point for many pharmaceutical companies working in this therapeutic area.
Can Singapore become a global hub for biotech?
Drug Discovery World
MARCH 13, 2024
According to Statista, revenue in this sector is expected to grow at an annual rate of 6.77%, resulting in a market volume of US$2,208m by 2028 1. In our study, we identified TOX2 as an important gene over-expressed and critical for NKTL survival. UK-based molecular diagnostics group Yourgene operates in Singapore.
Nutrigenomics: The Future of Personalized Nutrition
Roots Analysis
AUGUST 31, 2023
According to a study, around 20,000 genes are present in the human body, all of which interact with the nutrients in the food, either directly or indirectly. Nutrigenomics is the science studying the relationship between human genome, nutrition and health. Figure below presents an overview of nutrigenomics.
A history of blood cancer treatment
pharmaphorum
SEPTEMBER 13, 2022
Thanks to the dedicated efforts of doctors, patients, carers, and healthcare professionals, people diagnosed with blood cancer are now living longer, with a steady stream of more effective treatments entering the market each year. 2012 – The 100,000 Genomics Project begins. 2016–2022 — New treatments enter the market.
The era of precision neuroscience
Drug Discovery World
MARCH 6, 2024
Guiding neurological drug discovery and development to success The 20 years since the Human Genome Project has seen transformational advances in the molecular understanding of cancers and rare genetic diseases, leading to genetically informed, personalised selection of therapies and massively improved outcomes for many patients.
Let's personalize your content